Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cluster Analysis of Circulating Plasma Biomarkers in Prurigo Nodularis Reveals a Distinct Systemic Inflammatory Signature in African Americans
Nishadh Sutaria, Martin P. Alphonse, Melika Marani, et al.
Journal of Investigative Dermatology (2021) Vol. 142, Iss. 5, pp. 1300-1308.e3
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

A Review on the Safety of Using JAK Inhibitors in Dermatology: Clinical and Laboratory Monitoring
Christeen Samuel, Hannah Cornman, Anusha Kambala, et al.
Dermatology and Therapy (2023) Vol. 13, Iss. 3, pp. 729-749
Open Access | Times Cited: 107
Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis
Shawn G. Kwatra, Gil Yosipovitch, Franz J. Legat, et al.
New England Journal of Medicine (2023) Vol. 389, Iss. 17, pp. 1579-1589
Closed Access | Times Cited: 53
Single-Cell RNA Sequencing Reveals Dysregulated POSTN+WNT5A+ Fibroblast Subclusters in Prurigo Nodularis
Jay Patel, Marina Z. Joel, Kevin K. Lee, et al.
Journal of Investigative Dermatology (2024) Vol. 144, Iss. 7, pp. 1568-1578.e5
Closed Access | Times Cited: 15
Single-cell RNA sequencing defines disease-specific differences between chronic nodular prurigo and atopic dermatitis
Natalia Alkon, Frank P. Assen, T. Arnoldner, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 152, Iss. 2, pp. 420-435
Closed Access | Times Cited: 32
Chronic Prurigo Including Prurigo Nodularis: New Insights and Treatments
Svenja Müller, Claudia Zeidler, Sonja Ständer
American Journal of Clinical Dermatology (2023) Vol. 25, Iss. 1, pp. 15-33
Open Access | Times Cited: 27
Efficacy and Safety of Abrocitinib in Prurigo Nodularis and Chronic Pruritus of Unknown Origin
Shawn G. Kwatra, Zachary A. Bordeaux, Varsha Parthasarathy, et al.
JAMA Dermatology (2024) Vol. 160, Iss. 7, pp. 717-717
Open Access | Times Cited: 10
A Polygenic Risk Score for Predicting Racial and Genetic Susceptibility to Prurigo Nodularis
Chirag Vasavda, Guihong Wan, Mindy D Szeto, et al.
Journal of Investigative Dermatology (2023) Vol. 143, Iss. 12, pp. 2416-2426.e1
Closed Access | Times Cited: 18
Prurigo nodularis: new insights into pathogenesis and novel therapeutics
Viviane Liao, Hannah Cornman, Emily Ma, et al.
British Journal of Dermatology (2024) Vol. 190, Iss. 6, pp. 798-810
Closed Access | Times Cited: 7
Chronic prurigo
L. Misery
British Journal of Dermatology (2022) Vol. 187, Iss. 4, pp. 464-471
Closed Access | Times Cited: 25
The blood proteomic signature of prurigo nodularis reveals distinct inflammatory and neuropathic endotypes: A cluster analysis
Varsha Parthasarathy, Karen Cravero, Lillian Xu, et al.
Journal of the American Academy of Dermatology (2023) Vol. 88, Iss. 5, pp. 1101-1109
Open Access | Times Cited: 13
Spatial Mass Cytometry–Based Single-Cell Imaging Reveals a Disrupted Epithelial–Immune Axis in Prurigo Nodularis
Jay Patel, Junwen Deng, Anusha Kambala, et al.
Journal of Investigative Dermatology (2024) Vol. 144, Iss. 11, pp. 2501-2512.e4
Closed Access | Times Cited: 4
Efficacy and Safety of Nemolizumab in Patients With Prurigo Nodularis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Kunal Sinha, Tanya Sinha, Neeharika Muppa, et al.
Cureus (2025)
Open Access
Diagnosis and management of prurigo nodularis in skin of color patients
Akash Rau, Danyelle Dawes
Clinics in Dermatology (2025)
Closed Access
Modulation of Neuroimmune and Epithelial Dysregulation in Patients With Moderate to Severe Prurigo Nodularis Treated With Nemolizumab
Junwen Deng, Viviane Liao, Varsha Parthasarathy, et al.
JAMA Dermatology (2023) Vol. 159, Iss. 9, pp. 977-977
Open Access | Times Cited: 11
Circulating plasma IL-13 and periostin are dysregulated type 2 inflammatory biomarkers in prurigo nodularis: A cluster analysis
Varsha Parthasarathy, Karen Cravero, Junwen Deng, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 17
Single-cell RNA sequencing reveals dysregulated fibroblast subclusters in prurigo nodularis
Jay Patel, Marina Z. Joel, Kevin K. Lee, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 10
A randomized, double‐blinded, vehicle‐controlled clinical trial of topical cryosim‐1, a synthetic TRPM8 agonist, in prurigo nodularis
Myoung Eun Choi, Jeong Hyeon Lee, Chang Jin Jung, et al.
Journal of Cosmetic Dermatology (2024) Vol. 23, Iss. 3, pp. 931-937
Open Access | Times Cited: 3
Comprehensive plasma cytokine and chemokine profiling in prurigo nodularis reveals endotypes in Type 2 inflammation
Hannah Cornman, Jaya Manjunath, Sriya V. Reddy, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Severity, impact on quality of life and mental health burden of pruritus in prurigo nodularis: a cross-sectional study of a diverse patient cohort
Hannah Cornman, Katherine A. Whang, Emily Ma, et al.
British Journal of Dermatology (2024) Vol. 190, Iss. 4, pp. 571-572
Closed Access | Times Cited: 2
Dermatologic Disease-Directed Targeted Therapy (D3T2): The Application of Biomarker-Based Precision Medicine for the Personalized Treatment of Skin Conditions—Precision Dermatology
Philip R Cohen, Razelle Kurzrock
Dermatology and Therapy (2022)
Open Access | Times Cited: 11
Burden of Disease and Unmet Needs in the Diagnosis and Management of Atopic Dermatitis in Diverse Skin Types in Australia
Ashling Courtney, Diego J. Lopez, Adrian J. Lowe, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 11, pp. 3812-3812
Open Access | Times Cited: 6
Data independent acquisition reveals in-depth serum proteome changes in uremic pruritus
Zhao Wenjing, Ruizhi Tan, He Si-Yuan, et al.
Frontiers in Physiology (2024) Vol. 15
Open Access | Times Cited: 1
Immune stimulus exposure as a trigger for the development of chronic pruritus and circulating blood type 2 inflammation
Jaya Manjunath, Viviane Liao, Anusha Kambala, et al.
JAAD International (2024) Vol. 16, pp. 97-102
Open Access | Times Cited: 1
Dupilumab Therapy Modulates Circulating Inflammatory Mediators in Patients with Prurigo Nodularis
Aaron Bao, Emily Ma, Hannah Cornman, et al.
JID Innovations (2024) Vol. 4, Iss. 4, pp. 100281-100281
Open Access | Times Cited: 1
Chronic Prurigo
Julia Thünemann, Svenja Müller, Kerstin Steinbrink, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2024) Vol. 22, Iss. 6, pp. 813-823
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top